- Report
- September 2026
- 182 Pages
Global
From €3334EUR$3,545USD£2,781GBP
€3705EUR$3,939USD£3,090GBP
- Report
- November 2026
- 384 Pages
Global
From €5502EUR$5,850USD£4,590GBP
- Report
- November 2026
- 458 Pages
Global
From €5502EUR$5,850USD£4,590GBP
- Report
- July 2026
- 113 Pages
Global
From €4467EUR$4,750USD£3,727GBP
- Report
- July 2026
- 120 Pages
Global
From €4467EUR$4,750USD£3,727GBP
- Report
- January 2026
- 196 Pages
Global
From €4698EUR$4,995USD£3,919GBP
- Report
- August 2026
- 160 Pages
Global
From €3122EUR$3,320USD£2,605GBP
€3903EUR$4,150USD£3,256GBP
- Report
- February 2026
- 200 Pages
Europe
From €2812EUR$2,990USD£2,346GBP
- Report
- February 2024
- 72 Pages
South Korea
From €4703EUR$5,000USD£3,923GBP
- Report
- January 2023
- 195 Pages
Latin America
From €4703EUR$5,000USD£3,923GBP
- Report
- June 2022
- 55 Pages
India
From €4703EUR$5,000USD£3,923GBP
- Report
- June 2021
- 197 Pages
Latin America
From €3762EUR$4,000USD£3,138GBP
- Report
- February 2022
- 210 Pages
Global
From €4115EUR$4,375USD£3,432GBP
- Report
- September 2025
- 200 Pages
United States
From €2342EUR$2,490USD£1,954GBP
- Report
- August 2025
- 200 Pages
United States
From €2342EUR$2,490USD£1,954GBP
- Report
- October 2023
- 207 Pages
India
From €1857EUR$1,975USD£1,550GBP
€3715EUR$3,950USD£3,099GBP
- Report
- August 2025
- 136 Pages
Middle East
From €5596EUR$5,950USD£4,668GBP
- Report
- June 2025
- 100 Pages
Global
From €5596EUR$5,950USD£4,668GBP
- Report
- June 2025
- 137 Pages
United States
From €5596EUR$5,950USD£4,668GBP
- Report
- May 2025
- 156 Pages
Global
From €5596EUR$5,950USD£4,668GBP

The Mycoplasma market within the context of Diagnostics is a rapidly growing sector. Mycoplasma are a type of bacteria that can cause a range of diseases in humans and animals. Diagnostic tests for Mycoplasma are used to detect the presence of the bacteria in a patient's sample. These tests are used to diagnose and monitor the progression of Mycoplasma-related diseases, as well as to monitor the effectiveness of treatments.
Mycoplasma diagnostic tests are used in a variety of settings, including clinical laboratories, research laboratories, and veterinary clinics. The tests are available in a variety of formats, including ELISA, PCR, and culture-based assays.
The Mycoplasma diagnostic market is expected to continue to grow in the coming years, driven by the increasing prevalence of Mycoplasma-related diseases, the development of new diagnostic technologies, and the increasing demand for rapid and accurate diagnostic tests.
Some of the major companies in the Mycoplasma diagnostic market include Bio-Rad Laboratories, Thermo Fisher Scientific, Merck KGaA, Becton Dickinson, and Roche Diagnostics. Show Less Read more